Jade Biosciences, Inc.
USD17.75
-0.84 (-4.52%)
CEO
Tom Frohlich
IPO Date
2025-04-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.01
Prev. Close
$18.59
Day Low
$17.31
Day High
$19.43
52W Low
$6.57
52W High
$28.00
Market Cap
$0.58B
Volume
0.99M
| 226,875 |
| $14.81 |
| 13 Feb 2026 | Balta Elizabeth | See Remarks | A-Award | Acquired | 168,750 | $14.81 |
| 13 Feb 2026 | Balta Elizabeth | See Remarks | A-Award | Acquired | 28,125 | $0.00 |
| 13 Feb 2026 | Frohlich Tom | director, officer: Chief Executive Officer | A-Award | Acquired | 472,500 | $14.81 |
| 13 Feb 2026 | Frohlich Tom | director, officer: Chief Executive Officer | A-Award | Acquired | 78,750 | $0.00 |
| 13 Feb 2026 | King Andrew James | See Remarks | A-Award | Acquired | 41,250 | $0.00 |
| 13 Feb 2026 | King Andrew James | See Remarks | A-Award | Acquired | 247,500 | $14.81 |
| 8 Oct 2025 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | Acquired | 1,333,126 | $9.14 |
| 8 Oct 2025 | Fairmount Funds Management LLC | director, 10 percent owner: | A-Award | Acquired | 855,047 | $0.00 |